VanEck Biotech ETF Rating → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free BBH Stock Alerts $164.59 +0.77 (+0.47%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy2.59Holdings in BBH have an aggregate rating of Moderate Buy based on 408 analyst ratings issued in the past year covering 25 companies (100.0% of the portfolio).BBH Aggregate Price Target$191.6016.41% UpsideHigh Prediction$253.69Average Prediction$191.60Low Prediction$137.52Holdings in BBH have an aggregate price target of $191.60 and a range of $137.52 to $253.69 covering 25 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.81%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑9.87%VRTXVertex Pharmaceuticals$455.34+2.8%4 of 5 stars2.50$438.62 -3.7%24Analyst ForecastInsider SellingNews CoverageHigh Trading Volume8.06%MRNAModerna$142.55-5.9%3 of 5 stars2.24$126.46 -11.3%17Insider Selling7.76%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume7.32%GILDGilead Sciences$64.27+0.3%5 of 5 stars2.35$83.69 30.2%17News CoverageGap DownHigh Trading Volume4.51%BIIBBiogen$224.94+2.2%5 of 5 stars2.65$286.50 27.4%26Analyst ForecastShort Interest ↑News Coverage4.32%IQVIQVIA$219.09-1.5%4 of 5 stars2.80$257.57 17.6%15High Trading Volume4.11%ICLRICON Public$324.82+0.6%4 of 5 stars3.00$342.56 5.5%9Analyst ForecastNews Coverage4.00%ARGXargenx$371.02+2.4%3 of 5 stars2.71$520.68 40.3%21Analyst ForecastShort Interest ↓Positive News3.42%ILMNIllumina$104.28+3.2%5 of 5 stars2.30$164.65 57.9%20Short Interest ↑3.22%BGNEBeiGene$148.85-3.5%3 of 5 stars2.80$251.93 69.3%10Short Interest ↓News CoveragePositive NewsGap Down2.64%NBIXNeurocrine Biosciences$135.41-0.9%5 of 5 stars2.80$150.85 11.4%25Analyst ForecastInsider SellingPositive NewsGap DownHigh Trading Volume2.60%NTRANatera$106.53-3.3%2 of 5 stars3.00$98.47 -7.6%15Insider Selling2.52%TECHBio-Techne$77.19-0.1%4 of 5 stars2.73$81.00 4.9%112.39%BMRNBioMarin Pharmaceutical$75.07+0.8%5 of 5 stars2.57$106.11 41.3%21Insider Selling2.38%BNTXBioNTech$100.60+1.9%2 of 5 stars2.20$111.70 11.0%10Analyst ForecastShort Interest ↓2.36%SRPTSarepta Therapeutics$129.86+4.3%5 of 5 stars2.80$164.00 26.3%15Analyst ForecastHigh Trading Volume2.20%CRLCharles River Laboratories International$208.44-0.6%5 of 5 stars2.64$255.27 22.5%11Short Interest ↓Analyst RevisionNews Coverage1.93%QGENQiagen$43.26+1.5%4 of 5 stars2.56$50.95 17.8%91.86%ALNYAlnylam Pharmaceuticals$148.43-1.1%5 of 5 stars2.59$216.19 45.6%17Insider SellingHigh Trading Volume1.84%INCYIncyte$57.79+0.9%5 of 5 stars2.44$73.69 27.5%18Short Interest ↓Positive NewsHigh Trading Volume1.66%EXASExact Sciences$45.45+0.4%4 of 5 stars2.92$95.40 109.9%131.62%RGENRepligen$149.09+0.6%5 of 5 stars2.89$197.75 32.6%9Positive NewsHigh Trading Volume0.87%CRSPCRISPR Therapeutics$53.74-0.6%2 of 5 stars2.31$73.46 36.7%16Short Interest ↑Analyst Revision0.75%CYTKCytokinetics$48.51-1.2%4 of 5 stars2.82$74.88 54.4%17Analyst Forecast This page (NASDAQ:BBH) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
